Kennedy-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
642
Total Value
4186180323
Accession Number
0000884589-25-000006
Form Type
13F-HR
Manager Name
Kennedy-Capital-Management
Data Enrichment
97% identified
621 identified21 unidentified

Holdings

642 positions • $4.2B total value
Manager:
Search and click to pin securities to the top
Page 33 of 33
Cullinan Therapeutics, Inc.
Shares:11.6K
Value:$88.1K
% of Portfolio:0.0% ($88.1K/$4.2B)
Design Therapeutics, Inc.
Shares:14.4K
Value:$55.5K
% of Portfolio:0.0% ($55.5K/$4.2B)